Geelong Hospital

Geelong, Victoria 3220

0 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumors, Bleeding, Breast Cancer, Cancer, Dementia, Depression, Frailty, Functional Disability, HER2-positive Breast Cancer, Heart Disease, Lung Cancer, Relapsed or Refractory Follicular Lymphoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma — Running, not enrolling
• A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors — Running, not enrolling
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT) — Running, not enrolling
• PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer — Completed
• Aspirin in Reducing Events in the Elderly — Status unconfirmed